Volume 271, Number 47,
Issue of November 22, 1996
pp. 30068-30076
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Human RAD2 Homolog 1 5
- to 3
-Exo/Endonuclease Can Efficiently
Excise a Displaced DNA Fragment Containing a 5
-Terminal Abasic
Lesion by Endonuclease Activity*
(Received for publication, July 17, 1996, and in revised form, September 4, 1996)
Michael S.
DeMott
,
Binghui
Shen
§¶,
Min S.
Park
§,
Robert
A.
Bambara
and
Seymour
Zigman

**
From the Departments of
Biochemistry and
Ophthalmology, University of Rochester School of Medicine and
Dentistry, Rochester, New York 14642 and § Life Science
Division, Los Alamos National Laboratory,
Los Alamos, New Mexico 87545
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
Repair of abasic lesions, one of the most common
types of damage found in DNA, is crucial to an organism's
well-being. Studies in vitro indicate that after
apurinic-apyrimidinic endonuclease cleaves immediately upstream of a
baseless site, removal of the 5
-terminal sugar-phosphate residue is
achieved by deoxyribophosphodiesterase activity, an enzyme-mediated
-elimination reaction, or by endonucleolytic cleavage downstream of
the baseless sugar. Synthesis and ligation complete repair.
Eukaryotic RAD2 homolog 1 (RTH1) nuclease, by genetic and biochemical
evidence, is involved in repair of modified DNA. Efficient endonucleolytic cleavage by RTH1 nuclease has been demonstrated for
annealed primers that have unannealed 5
-tails. In vivo,
such substrate structures could result from repair-related strand
displacement synthesis. Using 5
-tailed substrates, we examined the
ability of human RTH1 nuclease to efficiently remove 5
-terminal abasic residues. A series of upstream primers were used to increasingly displace an otherwise annealed downstream primer containing a 5
-terminal deoxyribose-5-phosphate. Until displacement of the first
annealed nucleotide, substrates resisted cleavage. With further
displacement, efficient cleavage occurred at the 3
-end of the tail.
Therefore, in combination with strand displacement activity, RTH1
nucleases may serve as an important alternative to other pathways in
repair of abasic sites in DNA.
INTRODUCTION
Abasic lesions occur in DNA for several reasons, including
spontaneous depurination (1), release of the base from a damaged sugar
residue, or enzymatic removal of an inappropriate (e.g. uracil) or damaged (e.g. alkylated, deaminated, or oxidized)
base by specialized glycosylases (2). Timely repair of abasic lesions is necessary, since during replication the lesion could lead to potentially lethal or mutagenic substitutions (3).
Repair of an abasic site is predominantly initiated by an
apurinic-apyrimidinic (AP)1 endonuclease
that cleaves immediately upstream of the baseless sugar, creating a
3
-hydroxyl terminus and a 5
-deoxyribose-5-phosphate terminus (4, 5).
The next step, removal of the baseless sugar from the downstream
strand, likely occurs by one of three distinct mechanisms.
One mechanism involves removal of 5
-terminal sugar-phosphate residues
by a Mg2+-dependent hydrolytic reaction, which
releases 2-deoxyribose-5-phosphate. The activity responsible for this
reaction, deoxyribophosphodiesterase (dRpase), was discovered in
Escherichia coli (6). It was later shown to result from
cleavage by either exonuclease I (7, 8) or the RecJ protein (9). The
product of the RecJ gene was previously identified as a
single strand-specific 5
- to 3
-exonuclease (10). Nonetheless, enzymes
with dRpase activity have no associated double strand-specific 5
- to
3
-exonuclease function, so only a 1-nucleotide gap is produced after
removal of the baseless sugar. A DNA polymerase fills in the single
gap, and then a DNA ligase fuses the nick. There is support for this
pathway, known as base excision repair. It has been shown in
vitro that the majority of uracil residues in DNA are repaired by
replacing a single nucleotide (11), and this pathway has been
reconstituted with purified enzymes, one of which was the RecJ protein
(12). There is also evidence of dRpase activity in Deinococcus
radiodurans (13) and in humans (14), but these activities have
been only partially purified and, therefore, have not yet been linked
with a specific gene.
Another mechanism entails removal of a 5
-terminal baseless
sugar-phosphate residue by a
-elimination reaction, releasing unsaturated deoxyribose-phosphate derivatives. The
C(3
)-O-P bond 3
to a 5
-terminal abasic site is
extremely labile, with a half-life of about 2 h in the absence of
any
-elimination catalysts (e.g. spermine or basic
proteins), prompting some to propose that enzymatic removal of the
sugar-phosphate residue may not be necessary (15, 16). Others have
demonstrated that a
-elimination reaction can be catalyzed by the
Fpg protein in E. coli (17) and by DNA polymerase
in a
reconstituted system (18).
A third mechanism involves removal of 5
-terminal sugar-phosphate
residues by endonucleolytic cleavage downstream of the baseless sugar.
Previous studies indicate that the 5
- to 3
-exonuclease activity of
E. coli DNA polymerase I (6, 19) and human DNase IV (14, 19)
cannot release free 2-deoxyribose-5-phosphate from the 5
-terminus at a
single strand break in DNA. Although these enzymes can
endonucleolytically remove the abasic residue as part of small
oligonucleotides, cleavage occurs at a slow rate (6, 14, 19).
DNase IV and the 5
-nuclease domain of E. coli DNA
polymerase I are reported to belong to a class of enzymes the members
of which share structural and functional homology (20). This class includes: the Saccharomyces pombe RAD2 protein (21); the
product of the YKL510 open reading frame (21), called RTH1 (22); murine flap endonuclease 1 (23); human RTH1 (also called flap endonuclease 1)
(24); and a calf 5
- to 3
-exo/endonuclease (25, 26), now called calf
RTH1 (27). Functional homology among these enzymes includes an
endonuclease activity specific for structures containing unannealed
5
-tails or overhanging flaps (20, 25, 26, 28, 36). Several of these
enzymes also have been implicated in repair of modified DNA (22, 29)
and in the processing of Okazaki fragments (27, 30).
Recent work with calf RTH1 and murine flap endonuclease 1 revealed that
both exonuclease and endonuclease activities are enhanced when an
upstream strand forms a nick structure directly adjacent to the
annealed region of a downstream strand, whether fully annealed or
bearing an unannealed 5
-tail (25, 28). These findings suggest that
RTH1 nucleases prefer specific substrate structures to efficiently
induce exonuclease and endonuclease cleavage. This led us to
investigate whether removal of 5
-terminal baseless sugars as small
oligonucleotides could be enhanced by simulating strand displacement
synthesis. Such substrate structures may arise from a DNA polymerase
extending the resulting upstream strand after an AP endonuclease
cleaves at an internal abasic site but before removal of the baseless
sugar-phosphate residue.
EXPERIMENTAL PROCEDURES
Materials
Unless otherwise noted, DNA modification enzymes
were from Boehringer Mannheim. Oligonucleotides were from Genosys (The
Woodlands, TX). Radiolabeled nucleotides were from DuPont NEN.
Sequenase version 2.0 was from U. S. Biochemical Corp. Nickel
nitrilotriacetic acid (NTA)-agarose resin was from Qiagen.
MicropureTM EZ minicolumns were from Amicon, Inc. (Beverly,
MA). Polyethyleneimine (PEI) cellulose TLC plates (20 × 20 cm)
were from EM Science (via VWR Scientific). All other reagents,
including 2-deoxyribose-5-phosphate, were from
Sigma.
Preparation of Human RTH1 Nuclease
Recombinant human RTH1
was obtained from bacteria using the T7 RNA expression system (31)
following the procedure of Shen et al. (24). Briefly, the
coding sequence for human RTH1 was cloned into the expression vector
pET-28b (Novagen) upstream and in frame with the coding sequence for 6 histidine residues. The resulting plasmid, pET-FCH, was transformed
into E. coli strain BL21(DE3)pLysS (31). Transformants
were grown at 37 °C and induced with a final concentration of 1 mM isopropyl-1-thio-
-D-galactopyranoside for
3 h. Cells were collected by centrifugation and lysed by
sonication. The recombinant protein, which contains the entire amino
acid sequence for human RTH1 with a histidine tag at the C-terminal end, was purified by nickel nitrilotriacetic acid-agarose column chromatography as recommended by Qiagen. Fractions were collected and
tested for 5
- to 3
-exonuclease and -endonuclease activities as
described previously (25, 26). Active fractions were pooled and further
purified by hydroxylapatite as described in Murante et al.
(25) for calf RTH1. The final preparation was ~95% pure according to
analysis by SDS-PAGE stained with silver. Purified enzyme (0.15 mg/ml)
was dialyzed into a storage buffer (20% glycerol, 50 mM
NaCl, 50 mM Tris-HCl, pH 7.5, 1 mM
dithiothreitol, and 1 mM EDTA and EGTA) and then stored at
80 °C.
3
-Radiolabeled Substrates with and without an Abasic Residue at
the 5
-Terminus
For control experiments using substrates without
an abasic residue at the 5
-terminus, a 22-mer oligonucleotide
(M22; Table I) with a deoxyuridine at the
5
-terminus was annealed to a complementary template (T44;
Table I) so that a single unpaired guanine nucleotide remained at the
5
-terminus of the template. The primer M22 was radiolabeled by template-directed incorporation of
[
-32P]dCTP (3000 Ci/mmol) at its 3
-terminus using
Sequenase (version 2.0). The resulting 23-mer (D*; Table I) primer
with a labeled 3
-terminus and a 5
-terminal deoxyuridine was gel
purified and annealed to a 39-mer template (T39; Table I)
to form one of four primary substrates (D*:T39; Fig. 2).
For experiments using substrates with an abasic lesion at the
5
-terminus, a 39-mer oligonucleotide (M39; Table I) with
an internal deoxyuridine was 3
-radiolabeled as above, gel purified,
and then annealed to the template (T39). In every instance,
template T39 allowed at least 4 residues to overhang at
both 3
-ends to prevent degradation of the substrate by exonuclease III
at a later step (Fig. 1, lane 1). The substrate was stored
at
20 °C until use. For each experiment, a small aliquot was
removed from storage and further prepared as follows. The uracil base
was removed using uracil-DNA-glycosylase at 37 °C for 120 min. The
substrate was then incubated at 37 °C with 2 units of exonuclease
III for 35 min to specifically cleave on the 5
-side of the
deoxyribose-5-phosphate lesion. Under the conditions used, exonuclease
III continued to degrade the resulting upstream strand until only 3-5
nucleotides remained (Fig. 1, lane 5), at which point this
short primer could be easily displaced from the template. This formed
the second primary substrate (APD*:T39; Fig.
2). Exonuclease III was removed by centrifuging the substrate through a
MicropureTM EZ column (Amicon). A control experiment
confirmed that exonuclease III is completely removed by the minicolumn
(Fig. 1, lane 3).
Fig. 2.
Schematic of substrates. A series of
upstream primers was used to increasingly displace a fully annealed
downstream primer to simulate strand displacement synthesis. Thus, the
unannealed 5
-tails in this study were still complementary to the
template. Each downstream primer (D*, APD*, *D, or
*APD) was separately annealed to template T39
to form four primary substrates. In turn, each upstream primer
U17, U18, U19, U20, or
U22 was separately annealed to each primary substrate,
forming four different sets of the six structures shown above, one set
for each downstream primer. pS, position of an abasic
residue in those substrates that have downstream primers
(APD* or *APD); otherwise, deoxyuridine is
at this position. On substrates with an abasic residue, primer U17 leaves a 1-residue gap between the annealed nucleotides
of the two primers. In all other cases, the upstream primers form a
nick structure between the annealed nucleotides of the two primers. Numerical subscripts, number of sugar-phosphate residues.
Oligonucleotide sequences are shown in Table I.
[View Larger Version of this Image (12K GIF file)]
Fig. 1.
Experiments to monitor substrate design
procedures. *M39:T39 was incubated with
exonuclease III (exo III) for 60 min (lane 1) to
confirm that the overhanging 3
-ends prevent this enzyme from degrading
the substrate. *M39:T39 was treated with uracil-DNA glycosylase (UDG) for 120 min (lane
2). The latter sample was further treated with exonuclease III,
quickly centrifuged through a MicropureTM EZ minicolumn,
and then incubated for 75 min (lane 3) to confirm that the
minicolumn completely removes exonuclease III. A 5
-radiolabeled mononucleotide (dUMP) is shown in (lane 4). The sample from
lane 2 was also incubated with exonuclease III for 45 min
(lane 5) to confirm that this enzyme degrades the resulting
upstream primer after initial AP endonucleolytic cleavage. A different
substrate (*APD:T39) with a 5
-terminal
abasic residue was subjected to gel electrophoresis (lane 6)
to verify that this resolving method causes spontaneous detachment of
the baseless residue. Products were analyzed by 12% PAGE-urea and
autoradiography.
[View Larger Version of this Image (61K GIF file)]
5
-Radiolabeled Substrates with and without an Abasic Residue at
the 5
-Terminus
A 22-mer oligonucleotide (M22; Table
I) with a deoxyuridine at the 5
-terminus was 5
-radiolabeled using
polynucleotide kinase and [
-32P]ATP (3000 Ci/mmol).
For control experiments using substrates without an abasic residue at
the 5
-terminus, this labeled oligomer was annealed to a complementary
39-mer template (T39; Table I) to form a third primary
substrate (*D:T39; Fig. 2). For experiments using
substrates with an abasic lesion at the 5
-terminus, this labeled
oligomer was annealed to a complementary 44-mer template (T44) along with a 17-mer oligonucleotide (U17;
Table I) which annealed immediately upstream of the labeled 22-mer
oligonucleotide. The upstream and downstream strands were ligated using
T4 DNA ligase. The resulting 39-mer oligonucleotide with an internal, 5
-labeled deoxyuridine was gel purified and annealed to the 39-mer template used above (T39). The substrate was stored at
20 °C until use. For each experiment, a small aliquot was removed
from storage and further prepared as follows. The uracil base was
removed using uracil-DNA-glycosylase at 37 °C for 120 min. The
substrate was then incubated at 37 °C with 2 units of exonuclease
III for 35 min to specifically cleave on the 5
-side of the
deoxyribose-5-phosphate lesion. As above, exonuclease III degraded the
resulting upstream strand until only 3-5 nucleotides remained. This
formed the fourth primary substrate
(*APD:T39; Fig. 2). As above, exonuclease III was removed by centrifuging the substrate through a
MicropureTM EZ column (Amicon). Results on a PEI cellulose
TLC plate (Fig. 6A, lanes 1 and 2) confirm that
the minicolumn does not disrupt the labile 5
-terminal abasic residue;
it remained attached to the downstream primer for subsequent
experiments.
Fig. 6.
Cleavage of 5
-radiolabeled substrates with a
5
-terminal abasic lesion. A, no upstream primer or
U17, U18, or U19 was separately
annealed to primary substrate (*APD:T39). The
noted substrates were incubated at 37 °C for the indicated times
with no enzyme (lanes 1 and 2), 82 mM
NaOH (lanes 3 and 4), or human RTH1 nuclease
(lanes 5-8 and 12-15). A 5
-radiolabeled
mononucleotide (dUMP) is shown in lane 9. The
circle (lane 10) indicates the position of
2-deoxyribose-5-phosphate (Sigma) as observed by UV fluorescence. A 5
-radiolabeled dinucleotide (pUpT) is shown in lane 11. The lower bands in lanes 9 and 11 were determined to be inorganic phosphate.
B, no upstream primer or U18 was annealed to
primary substrates (*APD:T39 or
*D:T39). The noted substrates were incubated at 37 °C
for the indicated times with no enzyme (lanes 1 and
2), 102 mM NaOH (lanes 3-6), or
human RTH1 nuclease (lanes 10-16). A 5
-radiolabeled
mononucleotide (dUMP) is shown in lane 7. The
circle in lane 8 indicates the position of
2-deoxyribose-5-phosphate (Sigma) as observed by UV
fluorescence. A 5
-radiolabeled dinucleotide (pUpT) is shown in
lane 9. The lower bands in lanes 7 and
9 were determined to be inorganic phosphate. In lane
14, 2-deoxyribose-5-phosphate (Sigma) was added
to the reaction after 30 min, and then the mix was subjected to TLC.
Products in both panels were analyzed by thin layer chromatography and
autoradiography. Upper edges, solvent front.
[View Larger Version of this Image (72K GIF file)]
Assays
Enzyme reactions (25 µl) contained 50 mM Tris, pH 7.75, 6 mM MgCl2, 5%
(v/v) glycerol, 25 mg/ml bovine serum albumin, 50 pmol of an upstream
primer (U17, U18, U19,
U20, or U22; Table I) or no primer,
approximately 175 fmol of a radiolabeled primary substrate, and 0.15 µg of human RTH1 nuclease. The reactions were incubated at 37 °C,
and aliquots (5 µl) were removed at the indicated times. Reactions
were terminated by adding an equal volume of either 90% (v/v)
formamide with bromophenol blue and xylene cyanole markers for gel
electrophoresis or chilled 50 mM EDTA for TLC plate
analysis. For experiments using primary substrates
(D*:T39, APD*:T39, or *D:T39), reaction products were resolved on a 12% PAGE,
7 M urea sequencing gel. For experiments using the other
primary substrate (*APD:T39), samples were
analyzed by PEI cellulose thin layer chromatography (32). The mobile
phase was a mixture of 50% 1 M formic acid and 50% 1 M sodium formate (pH 3.4).
RESULTS
Previous work with calf RTH1 and murine flap endonuclease 1 showed
that endonuclease activity was efficient on annealed primers with
unannealed 5
-tails. In addition, cleavage was often enhanced when an
upstream primer formed a nick structure directly adjacent to the first
annealed nucleotide of the downstream primer (25, 28). Such structures
would result in vivo from a strand displacement synthesis
activity that extends the upstream strand at a single stranded break in
duplex DNA into the annealed region of the downstream strand, thereby
displacing a 5
-terminal segment of the downstream strand. This
prompted us to explore whether removal of 5
-terminal baseless sugars
as small oligonucleotides could be enhanced by simulating strand
displacement synthesis.
Substrates with an Abasic Lesion at the 5
-Terminus
Four
primary substrates were first created from which all additional
substrates were made. The two primary substrates (D*:T39 and *D:T39; see Fig. 2) with intact 5
-terminal
deoxyuridine residues and that were either 3
- or 5
-radiolabeled,
respectively, were created as outlined under "Experimental
Procedures." The other two primary substrates
(APD*:T39 and
*APD:T39) consisted of fully annealed
downstream primers having a baseless sugar-phosphate residue at the
5
-terminus and were either 3
- or 5
-radiolabeled, respectively.
Removal of a uracil base by uracil glycosylase is inefficient when the
base is located near the ends of DNA (data not shown; Ref. 14). In view
of this, we designed these primary substrates by either creating or
using oligonucleotides containing an internal deoxyuridine residue as
outlined under "Experimental Procedures." These oligomers were
annealed to a template (T39) and treated with uracil
glycosylase to create an internal abasic site. The template
(T39) (Table I) was designed to allow 4 residues to
overhang at both 3
-ends to prevent degradation of the substrate prematurely during the following step. The substrates were then treated
with exonuclease III, which has both AP endonuclease activity and 3
-
to 5
-exonuclease activity on recessed 3
-termini of double stranded
DNA. This nuclease initially cleaves on the 5
-side of the internal
abasic residue and then digests the resulting upstream strand. Thorough
digestion of the resulting upstream primer was necessary, since we
wanted to introduce several new upstream primers of increasing length.
Finally, exonuclease III was removed by centrifuging the substrates
through a MicropureTM EZ minicolumn (Amicon).
As shown in Fig. 1, several control experiments were
conducted to monitor the substrate design procedures. Fig. 1,
lane 1, depicts 5
-radiolabeled
*M39:T39 (Table I) treated with exonuclease III for 60 min to verify that the overhanging 3
-ends protect the
downstream primer and the template from being degraded. Fig. 1,
lane 2, shows the same substrate after it has been treated for 120 min with uracil-DNA glycosylase. The result verifies that the
substrate with an internal abasic lesion is stable when resolved by gel
electrophoresis, although some
-elimination reaction product is
evident. Fig. 1, lane 3, depicts the substrate from lane 2 after it had been further treated with exonuclease III, quickly centrifuged through a MicropureTM EZ minicolumn, and then
incubated at 37 °C for 75 min. This confirms that: 1) the uracil
base is mostly removed; 2) exonuclease III is an efficient AP
endonuclease; and 3) the minicolumn completely removes the exonuclease
III. Fig. 1, lane 5, shows the substrate from lane 2 after
it has been incubated with exonuclease III for 45 min, confirming that
the enzyme almost fully digests the upstream primer created after
initial AP endonuclease cleavage. Finally, in Fig. 1, lane
6, the 5
-radiolabeled primary substrate having a 5
-terminal
abasic lesion (*APD:T39) was gel
electrophoresed. The result indicates that a 5
-terminal baseless
sugar-phosphate residue is so labile that it spontaneously detaches
during the electrophoresis procedure. For this reason, experiments
using the primary substrate (*APD:T39) were
analyzed instead by PEI cellulose thin layer chromatography.
As shown in Fig. 2, four sets of six substrates were
designed with a series of upstream primers that increasingly displaced a fully complementary downstream primer. An approximately 270-fold molar excess of five increasingly long upstream primers
(U17, U18, U19, U20,
and U22; Table I) were separately annealed to the four
primary substrates (D*:T39,
APD*:T39, *D:T39, and
*APD:T39; see Fig. 2). These structures were
likely in equilibrium, so that part of the time, a segment of the
downstream primer was displaced by the upstream primers. The rest of
the time, the upstream primer was displaced. Unannealed 3
-tails,
however, are not suitable for cleavage by RTH1 nucleases. Using these
substrates, we tested the ability of human RTH1 nuclease to
endonucleolytically cleave downstream of either an intact 5
-terminal
deoxyuridine residue or a 5
-terminal abasic lesion. Cleavage was
monitored by the production of radiolabeled cleavage products over a
time course. Control experiments also were performed without upstream
primers.
Cleavage of 3
-Radiolabeled Substrates with an Intact
5
-Terminus
The first experiment was designed to determine the
cleavage specificity of human RTH1 nuclease on substrates made from
D*:T39 with an intact 5
-terminal deoxyuridine residue
(Fig. 3). Fig. 3, lanes 3-6, shows that
without an upstream primer, cleavage was inefficient and somewhat
nonspecific, releasing primarily 1 or 2 nucleotides. Once a nick
structure was formed by primer U17 positioned immediately
upstream of a fully annealed downstream primer, the 5
- to
3
-exonuclease function became predominant, releasing mostly 1 nucleotide (Fig. 3, lanes 8-11). Exonucleolytic cleavage
became even more efficient (Fig. 3, lanes 12-15) when the
primer (U18) was long enough to displace the 5
-terminal
nucleotide on the downstream primer. Here, the majority of substrate
was converted to product within the first 10 min, whereas the rest was
resistant to cleavage, perhaps because some downstream primers remained
completely unannealed. Cleavage activity shifted from exonucleolytic to
endonucleolytic as the upstream primer became long enough to displace
dimer (Fig. 3, lanes 18-21), trimer (Fig. 3, lanes
22-25), or pentamer (Fig. 3, lanes 27-30) unannealed tails on the downstream primer. The results indicate that cleavage always occurred on the 5
-side of the first annealed nucleotide at the
base of the tail. Cleavage was most efficient when the unannealed
5
-tail consisted of 2 residues. The results here are consistent with
an earlier finding, which showed that the nucleotide sequence of the
tail near the cleavage site can influence the cleavage efficiency and
position specificity of calf RTH1 nuclease (27).
Fig. 3.
Cleavage of 3
-radiolabeled substrates with
an intact 5
-terminus. No upstream primer or U17,
U18, U19, U20, or U22 was separately annealed to primary substrate (D*:T39) as
indicated. Each substrate was incubated at 37 °C with human RTH1
nuclease for the indicated times. Length markers are shown in lanes
7, 16, 17, and 26. Products were analyzed by 12%
PAGE-urea and autoradiography.
[View Larger Version of this Image (29K GIF file)]
Cleavage of 3
-Radiolabeled Substrates with a 5
-Terminal Abasic
Lesion
Next, the cleavage specificity of human RTH1 nuclease was
examined using substrates made from APD*:T39
that have a 3
-radiolabeled downstream primer with a baseless
sugar-phosphate residue at the 5
-terminus (Fig. 4). As
mentioned above, we found that gel electrophoresis of the substrates
caused detachment of the baseless sugar (Fig. 1, lane 6),
regardless of the conditions used. As a result, this experiment did not
distinguish deoxyribose-phosphate residues that were exonucleolytically
removed as monomers during the enzyme reaction from the baseless
residues that were detached after the reaction by the resolving method.
This problem is evident from the control with no enzyme. The downstream
primer, which started as a 23-mer oligonucleotide, was resolved as a
22-mer oligonucleotide. The difference in length between the substrate
and the cleavage products throughout these reactions was always 1 residue shorter than would normally be expected. Despite this
limitation, as the upstream primers became long enough to displace
dimer (Fig. 4, lanes 17-20), trimer (Fig. 4, lanes
21-24), and pentamer (Fig. 4, lanes 26-29) unannealed
tails on the downstream primer, human RTH1 nuclease efficiently cleaved
the tails at their 3
-end. Baseless sugar-phosphate residues were not
released as monomers either prematurely or during the reaction, because
results from an experiment using 5
-radiolabeled substrates made from
*APD:T39 and analyzed by thin layer
chromatography (see below) did not show significant release of
2-deoxyribose-5-phosphate or
-elimination products. In addition,
cleavage appeared appreciably more nonspecific when the upstream primer
(U17) and the first annealed nucleotide of the downstream
primer were separated by a single nucleotide gap (Fig. 4, lanes
8-11). This substrate
(U17:APD*:T39) closely resembles the structure that exists in vivo immediately after an AP
endonuclease cleaves at an internal abasic site in DNA. It represents
the only structure used in studies that first reported the ability of
DNase IV (human RTH1) to remove 5
-terminal baseless sugar residues as
part of small oligonucleotides (14, 19). The results shown in Fig. 4,
lanes 8-11, appear to correlate with the earlier findings, since those studies show inefficient release of dimers and trimers.
Fig. 4.
Cleavage of 3
-radiolabeled substrates with a
5
-terminal abasic lesion. No upstream primer or U17,
U18, U19, U20, or U22
was separately annealed to primary substrate
(APD*:T39) as indicated. Each substrate was
incubated at 37 °C with human RTH1 nuclease for indicated times.
Since 5
-terminal abasic lesions spontaneously detach during the
electrophoresis procedure, the difference in length between the
substrate and the cleavage products throughout these reactions was
always 1 residue shorter than would normally be expected. Length
markers are shown in lanes 7, 16, and 25.
Products were analyzed by 12% PAGE-urea and autoradiography.
[View Larger Version of this Image (51K GIF file)]
Cleavage of 5
-Radiolabeled Substrates with an Intact
5
-Terminus
To confirm that the tailed polymer segments were
removed endonucleolytically and not exonucleolytically, two additional
substrate sets (Fig. 2) were designed with 5
-radiolabeled downstream
primers. We retested the ability of human RTH1 nuclease to
endonucleolytically cleave unannealed 5
-tails by monitoring the
production of 5
-radiolabeled cleavage products over a time course.
The first experiment was performed using substrates made from primary
substrate (*D:T39) containing an intact 5
-terminal deoxyuridine residue (Fig. 5). Products were resolved on
a 12% PAGE-urea sequencing gel. Fig. 5, lanes 3-6,
confirms, as indicated earlier, that without an upstream primer,
cleavage was inefficient, although results here suggest that release of
a dinucleotide was favored. Fig. 5, lanes 7-10, confirms
that once a nick structure was formed by primer U17
positioned directly adjacent to a fully annealed downstream primer, 5
-
to 3
-exonuclease activity again was stimulated. As before,
exonucleolytic cleavage became more efficient (Fig. 5, lanes
14-17) when the primer (U18) was long enough to
displace the 5
-terminal nucleotide on the downstream primer. Cleavage
activity shifted from exonucleolytic to endonucleolytic as the upstream
primer became long enough to displace dimer (Fig. 5, lanes
18-21) or trimer (Fig. 5, lanes 22-25) unannealed
tails. Surprisingly, the results in Fig. 5, lanes 22-25,
appear to contradict the results from above (Fig. 3, lanes
22-25). Although the results above show that three nucleotides
were released, the results from this experiment indicate that only a
dinucleotide was released intact. A different experiment (data not
shown) confirmed this discrepancy and also indicated that the first 2 residues were again released as a separate dinucleotide even when the
longest primer (U22) was used. This conflict may be
reconciled, however, by considering the sequence of the fully
complementary downstream primers used in this study (Table I). The
first five bases (5
-UTCTT-3
) suggest that a stronger G-C pairing
immediately adjacent to the released dinucleotide could momentarily
hinder complete tail displacement. Earlier work by Murante et
al. (26) provided evidence of a model in which RTH1 nucleases
slide over the 5
-end of an unannealed tail and then track along the
tail before cleaving at the junction. Since the unannealed tails in
this earlier work were noncomplementary with the template, displacement
was always complete. In this study, incomplete tail displacement, even
if momentary, could provide an alternate structure suitable for
cleavage. Because the data from Fig. 3, lanes 22-25, do not
show significant levels of a product that would correspond to release
of only a dinucleotide, we further propose that the enzyme remained
associated with the substrate so it could cleave again once tail
displacement was complete. Also, cleavage was more efficient when the
unannealed 5
-tail consisted of only 2 residues. Perhaps when longer
primers (U20 and U22) were used, more of the
substrate may have formed alternate structures unsuitable for
cleavage.
Fig. 5.
Cleavage of 5
-radiolabeled substrates with
an intact 5
-terminus. No upstream primer or U17,
U18, U19, or U20 was separately
annealed to primary substrate (*D:T39) as indicated. Each
substrate was incubated at 37 °C with human RTH1 nuclease for
indicated times. Length markers are shown in lanes 11-13. Products were analyzed by 12% PAGE-urea and autoradiography.
[View Larger Version of this Image (49K GIF file)]
Cleavage of 5
-Radiolabeled Substrates with a 5
-Terminal Abasic
Lesion
This final experiment was performed using substrates made
from primary substrate (*APD:T39) containing
a baseless sugar-phosphate residue at the 5
-terminus (Fig.
6). As mentioned above, a 5
-terminal abasic lesion is
extremely labile. In this experiment, since the radioactive label is
attached to the lesion, the 5
-radiolabeled products had to be analyzed
by a method other than gel electrophoresis. We chose PEI cellulose thin
layer chromatography, because the labile substrates proved more stable
using this method.
Fig. 6A, lanes 1 and 2, depicts a control
reaction with no added enzyme using a substrate
(*APD:T39) without an upstream primer. Results confirm that most substrate molecules are unaffected by TLC
analysis. That is, the baseless sugar-phosphate residue remains attached to the downstream primer, with no significant increase in
spontaneous detachment after a 45-min incubation at 37 °C. To verify
that a sizable portion of the substrate present at the TLC plate origin
(Fig. 6A, lanes 1 and 2) actually had a
5
-terminal abasic lesion, we performed the same reaction in the
absence and presence, respectively, of NaOH (Fig. 6A, lanes
3 and 4). Sodium hydroxide is known to induce a
-elimination reaction (33), so that 5
-terminal baseless
sugar-phosphate residues are released as unsaturated derivatives of
deoxyribose-phosphate (17). Results show (Fig. 6A, lane 4)
that the released product is distinct from 2-deoxyribose-5-phosphate
(Sigma), shown in Fig. 6A, lane 10. Quantitation by a PhosphorImager (Molecular Dynamics) revealed that a
20-min incubation at 37 °C with 82 mM NaOH converted
34% of the substrate into a
-elimination product and another 18% into inorganic phosphate. Therefore, at least 52% of the primary substrate used for all the reactions depicted in Fig. 6A had
a 5
-terminal abasic lesion.
To test the ability of human RTH1 nuclease to exonucleolytically remove
the lesion, we performed reactions using the primary substrate
(*APD:T39) either with no upstream primer
(Fig. 6A, lanes 5 and 6), primer U17,
which leaves a 1-residue gap between the annealed nucleotides of the
two primers (Fig. 6A, lanes 7 and 8), or primer
U18, which forms a nick between the annealed nucleotides of
the two primers (Fig. 6A, lanes 12 and 13). In every case, there was no significant release of either a
-elimination product (Fig. 6A, lane 4) or
2-deoxyribose-5-phosphate (Fig. 6A, lane 10). We conclude
that human RTH1 nuclease does not function as either a
-elimination
catalyst or as a dRpase. The results here are consistent with earlier
studies, which indicated that DNase IV (human RTH1) was inhibited by
5
-terminal baseless sugar-phosphate residues (14, 19).
Although there was no release of a monomer product, after a 30-min
incubation with the enzyme, results from each reaction show evidence of
migration of the radioactive label away from the origin. In keeping
with the results obtained using 3
-radiolabeled substrates, this was
likely due to endonucleolytic cleavage downstream of the 5
-terminal
abasic site, so that small oligonucleotides were released. Another
reaction was performed (Fig. 6A, lanes 14 and 15)
using a substrate (U19:*APD:T39)
that used an upstream primer that could displace an unannealed dimer
tail. In this case, the result shows increased migration of the
radioactive label away from the origin, although cleavage product(s)
were not identifiable. A different experiment (data not shown) used
substrates made with primers U20 and U22 so
that the downstream primer was further displaced. Here, the results
were similar to that shown in Fig. 6A, lane 15.
Unfortunately, under the conditions used for TLC analysis,
oligonucleotides bearing the abasic lesion could not be resolved.
Additional control experiments were performed (Fig. 6B) to
verify the integrity of the substrate and the validity of the TLC analysis. Fig. 6B, lanes 3 and 4, depict a
reaction using a 5
-radiolabeled substrate (*D:T39) with
an intact 5
-terminal deoxyuridine either without or with,
respectively, 102 mM NaOH. The result confirms that an
intact 5
-terminal nucleotide is resistant to detachment during the
sodium hydroxide treatment used above. In the enzyme reactions shown in
Fig. 6A, neither
-elimination products nor 2-deoxyribose-5-phosphate were detectable. An alternative explanation for this result is that the rest of the substrate in some way retarded
the migration of the monomer cleavage products on the TLC plate. Three
additional reactions were performed to exclude this possibility. In the
first, a substrate (U18:*D:T39) with an
intact 5
-terminal deoxyuridine was incubated with the enzyme for 0 and
30 min, respectively, (Fig. 6B, lanes 10 and 11).
Based on results shown above (Fig. 5, lanes 14-17), the
terminal nucleotide should be exonucleolytically released. As
predicted, the cleavage product migrated to the same position on the
TLC plate as radiolabeled dUMP in the control (Fig. 6B,
lane 7). In the second reaction, a substrate
(U18:*APD:T39) having a
5
-terminal abasic lesion was also incubated with human RTH1 nuclease
(Fig. 6B, lanes 12-14). As before, no
-elimination
products or 2-deoxyribose-5-phosphate were detected (Fig. 6B,
lane 13). In Fig. 6B, lane 14, an additional aliquot of
the reaction was mixed with 2-deoxyribose-5-phosphate (Sigma) and then analyzed. The result shows that the
2-deoxyribose-5-phosphate in the mixed sample migrated to the same
position on the TLC plate as 2-deoxyribose-5-phosphate in the control
(Fig. 6B, lane 8). Finally, in the third reaction, two
substrates (U18:*D:T39 and U18:*APD:T39) were mixed and then
incubated with the enzyme (Fig. 6B, lanes 15 and
16). The result shows that a cleavage product migrated to
the same position as the product in lane 11 and dUMP in lane 7. Taken
together, these results rule out the possibility that migration of
monomer cleavage products on a TLC plate is retarded by other
components in the reaction. Detection of a cleavage product in the
third reaction also confirms that the enzyme remains active even in the
presence of a substrate that resists cleavage.
DISCUSSION
Genetic and biochemical evidence indicates that eukaryotic RTH1
nuclease participates in removal of modified nucleotides (22, 26, 29).
Previous work has shown that the exonucleolytic activity of this
nuclease was ineffective at removal of 5
-terminal abasic lesions (14,
19). Here we show that this nuclease can efficiently remove such
lesions by endonuclease activity. We have demonstrated that
endonucleolytic cleavage downstream of a 5
-terminal abasic lesion is
dependent on displacement of the downstream primer bearing the lesion.
Cleavage was most efficient when an upstream primer displaced the first
annealed nucleotide on the downstream primer. Further displacement of
the unannealed 5
-tail continued to stimulate cleavage, although not as
efficiently. Such structures are likely produced in vivo at
sites of single strand breaks in DNA by a strand displacement synthesis
activity. Single strand breaks are created during the initial stages of
repair of an abasic DNA lesion.
Abasic DNA lesions occur for a variety of reasons, including
spontaneous depurination at physiological temperature and pH (1, 34),
removal of uracil from DNA by a uracil glycosylase, or removal of
damaged bases by other specialized glycosylases. Some glycosylases
(e.g.
2,6-diamino-4-hydroxy-5N-formamidopyrimidine (Fapy) DNA
glycosylase) cleave the N-glycosyl bond holding the base and
also cleave on the 3
-side of the just formed baseless sugar (35). This
creates a suitable 5
-terminus on the downstream strand for eventual
ligation. In this scenario, removal of the baseless sugar from the
3
-terminus has been well characterized, occurring from cleavage by a
class II AP endonuclease (4, 5). This latter class of enzyme has both
3
-phosphodiesterase and 3
-phosphatase activities. However, not every
glycosylase has the ability to cleave the DNA backbone, so an internal
abasic site is often produced. Repair of an internal abasic lesion is predominantly initiated by a class II AP endonuclease, which cleaves on
the 5
-side of the baseless sugar, so that the 3
-terminus can support
primer extension (4, 5). Subsequent removal of the abasic residue from
the 5
-terminus must occur before the upstream and downstream strands
are ligated.
Previous studies have identified three distinct mechanisms for this
process. Two of these mechanisms entail removal of the baseless sugar
as a single residue, either by a hydrolytic reaction known as dRpase
activity (6, 14) or by an enzyme mediated
-elimination reaction (17,
18). In either case, the 1-nucleotide gap is filled by a DNA
polymerase, and the adjacent strands are joined by a ligase. There is
support for this pathway, known as base excision repair. Using both
bacterial and mammalian cell extracts, the majority of uracil residues
in DNA were repaired by replacing a single nucleotide (11). Base
excision repair also has been reconstituted with purified enzymes from
E. coli, one of which was the RecJ protein (12). In both
studies, however, some of the substrates used may have been resistant
to strand displacement synthesis, because the uracil residue to be
repaired was incorporated in a G-C-rich region. In addition, the latter study indicates that in the absence of dRpase activity provided by the
RecJ protein, longer repair patches were observed and were likely due
to the strand displacement and 5
-nuclease activities of E. coli DNA polymerase I. As noted before, it has been reported that
DNase IV and the 5
-nuclease domain of DNA polymerase I share structural and functional homology (20). Therefore, DNase IV (human
RTH1) would likely be responsible for longer repair patches in the
mammalian system. Yet another study found that E. coli Fpg/recj
double mutants retain capacity to repair abasic sites in DNA,
indicating the presence of a backup excision function (9).
The third mechanism by which 5
-terminal abasic lesions are repaired
involves endonucleolytic cleavage downstream of the baseless residue,
so that the lesion is removed as part of small oligonucleotides. Previous studies have shown that the 5
- to 3
-exonuclease activities of E. coli DNA polymerase I (6, 19) and human DNase IV (14, 19) are inhibited by a 5
-terminal deoxyribose-phosphate residue. Although the studies indicate that the enzymes can endonucleolytically remove the abasic residue as part of small oligonucleotides, they report that cleavage occurs at a slow rate. Rapid repair of an abasic
DNA lesion, the investigators conclude, necessitates a dRpase activity
that can rapidly remove free 2-deoxyribose-5-phosphate. The substrates
used in these earlier studies, however, were limited to the structure
obtained immediately after an AP endonuclease has cleaved at an
internal abasic site. The results in our study are consistent with the
earlier results, since we show that human RTH1 nuclease is inhibited
until the first annealed nucleotide on the downstream primer is
displaced.
Recent work with the calf RTH1 nuclease indicates that the enzyme can
remove short RNA segments from duplex DNA when the segments are part of
unannealed 5
-tails. Most initiator RNA removal from Okazaki fragments
in mammals is thought to occur through the combined endonucleolytic
action of RNase H and exonucleolytic action of RTH1 nuclease (30).
However, calf RTH1 nuclease alone was able to remove the RNA segment
endonucleolytically when the downstream primer was sufficiently
displaced (27). This latter result was obtained in vitro
through experiments similar to the work presented here. When downstream
primers containing an RNA-DNA junction were increasingly displaced by
an upstream primer to simulate strand displacement synthesis, a
substrate for efficient endonucleolytic cleavage by RTH1 nuclease was
created. In this way, RTH1 class nucleases can participate in the
processing of Okazaki fragments through two pathways during lagging
strand DNA replication. A role for RTH1 nuclease in DNA replication has
gained further support by a recent finding that null mutants in the
yeast RTH1 nuclease are defective in DNA replication and show elevated
levels of spontaneous mitotic recombination (22). This is indicative of
a suppression of Okazaki fragment processing. Interestingly, these
mutants were also sensitive to methyl methane-sulfonate. This
DNA-damaging agent induces lesions that are initially repaired by
removal of the alkylated base by a glycosylase, thereby creating an
abasic DNA lesion. Sommers et al. (22) surmised that the
null mutants were incapable of removing the abasic lesion from the
5
-terminus after AP endonucleolytic cleavage.
Murante et al. (26) provided evidence that RTH1 nucleases
slide over the free end of an unannealed 5
-tail and then track along
the tail to its base before cleaving endonucleolytically. Other more
recent work extends this model by revealing that the enzyme has a high
degree of tolerance for bulky adducts along the tail, including
cis-platinum, biotin, and tertiary butyl silyl adducts (29).
This suggests that RTH1 nucleases can participate in repair of a
variety of different lesions, when working in combination with a DNA
strand displacement activity. This model implies that the structure of
the 5
-terminal residue of the tail would be important for substrate
recognition, tracking, or both. However, our results indicate that the
base moiety on the terminal deoxyribose may not be crucial when the
unannealed tail is at least 2 residues long. This is consistent with
the earlier observation that calf RTH1 nuclease can also slide past a
7-methylguanine located at the 5
-terminus of the tail (26). In this
case, perhaps the penultimate base also can participate in recognition
and/or tracking. For the special case in which the baseless sugar forms
an unannealed 1-residue 5
-tail, the base moiety might be more crucial
for recognition or cleavage, since we and others (6, 14, 19) did not
observe dRpase activity by this class of enzyme.
The results presented here, together with previous work, suggest that
5
-terminal abasic lesions in mammals are repaired by at least two
pathways. The first involves removal of the baseless sugar-phosphate
residue by the action of either a dRpase or a
-elimination reaction.
The second involves removal of the abasic lesion as part of an
oligomer. Here we show that the RTH1 nuclease, implicated by both
genetic and biochemical evidence in the direct removal of damaged
nucleotides, has the appropriate substrate specificity to participate
in the latter pathway. For the reaction to occur efficiently, the
5
-abasic residue and one or more additional nucleotides must be
displaced from the template. The RTH1 nuclease can then slide over the
5
-end of the displaced tail, move to the point where the tail is
annealed to the template, and then cleave endonucleolytically. Since
RTH1 nuclease is also involved in both Okazaki fragment processing and
the repair of adduct-damaged bases, the current results highlight the
range of important functions in which this enzyme participates.
FOOTNOTES
*
This research was supported in part by National Institutes
of Health Grants EY00459 (to S. Z.) and GM24441 (to R. A. B.), Los
Alamos National Laboratory Directed Research and Development Grant XL2E
(to M. S. P.), Department of Energy Grant KP-0302000 (to M. S. P.),
and a student fellowship from Canon USA, Inc., via Fight for Sight,
Inc. (to M.S.D.). The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact. .
This work has been designated in memory of Harold Gray by Fight for
Sight, Inc., an affiliate of Prevent Blindness America.
¶
Present address: Dept. of Cell and Tumor Biology, City of Hope
National Medical Center, Duarte, CA 91010.
**
To whom correspondence should be addressed: University of Rochester
Medical Center, Dept. of Ophthalmology, Box 314, 601 Elmwood Ave.,
Rochester, NY 14642. Tel.: 716-275-1467; Fax: 716-473-3411.
1
The abbreviations used are: AP,
apurinic-apyrimidinic; dRpase, deoxyribophosphodiesterase; RTH1, RAD2
homolog 1; PEI, polyethyleneimine; PAGE, polyacrylamide gel
electrophoresis; D, downstream primer; M, miscellaneous primer; T,
template; U, upstream primer.
Acknowledgments
We thank Joanne B. Schultz and Dr. C. Palaniappan for helpful advice. We also thank Richard S. Murante and
Dr. Leigh A. Henricksen for thoughtful discussions and critical reading
of the manuscript.
REFERENCES
-
Lindahl, T., and Nyberg, B.
(1972)
Biochemistry
11,
3610-3618
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Friedberg, E. C., Walker, G. C., and Siede, W.
(1995)
DNA Repair and Mutagenesis, pp. 139-169, ASM Press, Washington, D. C.
-
Wallace, S. S.
(1994)
Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med.
66,
579-589
-
Mosbaugh, D. W., and Linn, S.
(1980)
J. Biol. Chem.
255,
11743-11752
[Medline]
[Free Full Text]
-
Doetsch, P. W., and Cunningham, R. P.
(1990)
Mutat. Res.
236,
173-210
[Medline]
[Medline]
[Order article via Infotrieve]
-
Franklin, W. A., and Lindahl, T.
(1988)
EMBO J.
7,
3617-3622
[Medline]
[Medline]
[Order article via Infotrieve]
-
Sandigursky, M., and Franklin, W. A.
(1992)
Nucleic Acids Res.
20,
4699-4703
[Medline]
[Abstract/Free Full Text]
-
Sandigursky, M., and Franklin, W. A.
(1994)
Nucleic Acids Res.
22,
247-250
[Medline]
[Abstract/Free Full Text]
-
Dianov, G., Sedgwick, B., Daly, G., Olsson, M., Lovett, S., and Lindahl, T.
(1994)
Nucleic Acids Res.
22,
993-998
[Medline]
[Abstract/Free Full Text]
-
Lovett, S. T., and Kolodner, R. D.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
2627-2631
[Medline]
[Abstract/Free Full Text]
-
Dianov, G., Price, A., and Lindahl, T.
(1992)
Mol. Cell. Biol.
12,
1605-1612
[Medline]
[Abstract/Free Full Text]
-
Dianov, G., and Lindahl, T.
(1994)
Curr. Biol.
4,
1069-1076
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mun, C., Del Rowe, J., Sandigursky, M., Minton, K. W., and Franklin, W. A.
(1994)
Radiat. Res.
138,
282-285
[Medline]
[Medline]
[Order article via Infotrieve]
-
Price, A., and Lindahl, T.
(1991)
Biochemistry
30,
8631-8637
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bailly, V., and Verly, W. G.
(1988)
Biochem. J.
253,
553-559
[Medline]
[Medline]
[Order article via Infotrieve]
-
Bailly, V., and Verly, W. G.
(1989)
Biochem. J.
259,
761-768
[Medline]
[Medline]
[Order article via Infotrieve]
-
Graves, R. J., Felzenszwalb, I., Laval, J., and O'Connor, T. R.
(1992)
J. Biol. Chem.
267,
14429-14435
[Medline]
[Abstract/Free Full Text]
-
Matsumoto, Y., and Kim, K.
(1995)
Science
269,
699-702
[Medline]
[Abstract/Free Full Text]
-
Price, A.
(1992)
FEBS Lett.
300,
101-104
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Robins, P., Pappin, D. J. C., Wood, R. D., and Lindahl, T.
(1994)
J. Biol. Chem.
269,
28535-28538
[Medline]
[Abstract/Free Full Text]
-
Jacquier, A., Legrain, P., and Dujon, B.
(1992)
Yeast
8,
122-132
-
Sommers, C. H., Miller, E. J., Dujon, B., Prakash, S., and Prakash, L.
(1995)
J. Biol. Chem.
270,
4193-4196
[JBC][Medline]
[Abstract/Free Full Text]
-
Harrington, J. J., and Lieber, M. R.
(1994)
Genes Dev.
8,
1344-1355
[Medline]
[Abstract/Free Full Text]
-
Shen, B., Nolan, J. P., Sklar, L. A., and Park, M. S.
(1996)
J. Biol. Chem.
271,
9173-9176
[JBC][Medline]
[Abstract/Free Full Text]
-
Murante, R. S., Huang, L., Turchi, J. J., and Bambara, R. A.
(1994)
J. Biol. Chem.
269,
1191-1196
[Medline]
[Abstract/Free Full Text]
-
Murante, R. S., Rust, L., and Bambara, R. A.
(1995)
J. Biol. Chem.
270,
30377-30383
[JBC][Medline]
[Abstract/Free Full Text]
-
Murante, R. S., Rumbaugh, J. A., Barnes, C. J., Norton, J. R., and Bambara, R. A.
(1996)
J. Biol. Chem.
271,
25888-25897
[JBC][Medline]
[Abstract/Free Full Text]
-
Harrington, J. J., and Lieber, M. R.
(1994)
EMBO J.
13,
1235-1246
[Medline]
[Medline]
[Order article via Infotrieve]
-
Barnes, C. J., Wahl, A. F., Shen, B., Park, M. S., and Bambara, R. A. (1996) J. Biol. Chem. 271, in press
-
Turchi, J. J., Huang, L., Murante, R. S., Kim, Y., and Bambara, R. A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
9803-9807
[Medline]
[Abstract/Free Full Text]
-
Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W.
(1990)
Methods Enzymol.
185,
60-89
[Medline]
[Medline]
[Order article via Infotrieve]
-
Randerath, K., and Randerath, E.
(1967)
Methods Enzymol.
12A,
323-347
-
Mazumder, A., Gerlt, J. A., Absalon, M. J., Stubbe, J., Cunningham, R. P., Withka, J., and Boulton, P. H.
(1991)
Biochemistry
30,
1119-1126
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lindahl, T.
(1993)
Nature
362,
709-715
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
O'Connor, T. R., and Laval, J.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
5222-5226
[Abstract/Free Full Text]
-
Lyamichev, V., Brow, M. A. V., and Dahlberg, J. E.
(1993)
Science
260,
778-783
[Medline]
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore